Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.

Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D.

Genet Epidemiol. 2001 Jul;21(1):1-18.

PMID:
11443730
2.

How many more breast cancer predisposition genes are there?

Easton DF.

Breast Cancer Res. 1999;1(1):14-7. Epub 1999 Aug 23. No abstract available.

3.

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.

Olsen JH, Hahnemann JM, Børresen-Dale AL, Brøndum-Nielsen K, Hammarström L, Kleinerman R, Kääriäinen H, Lönnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD Jr, Tucker M.

J Natl Cancer Inst. 2001 Jan 17;93(2):121-7.

4.

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Thompson D, Easton D; Breast Cancer Linkage Consortium.

Am J Hum Genet. 2001 Feb;68(2):410-9. Epub 2001 Jan 19.

5.

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL.

Am J Hum Genet. 2001 Feb;68(2):420-31. Epub 2000 Dec 27.

7.

Hormonal carcinogenesis.

Henderson BE, Feigelson HS.

Carcinogenesis. 2000 Mar;21(3):427-33. Review.

8.

Risk models for familial ovarian and breast cancer.

Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF.

Genet Epidemiol. 2000 Feb;18(2):173-90.

PMID:
10642429
9.

Inherited genetic predisposition in breast cancer. A population-based perspective.

Rebbeck TR.

Cancer. 1999 Dec 1;86(11 Suppl):2493-501. Review.

PMID:
10630175
10.

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ.

Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7.

11.

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.

Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M.

Am J Hum Genet. 1999 May;64(5):1371-7.

12.

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Chang-Claude J, Sobol H, Weber B, Stratton MR, Easton DF.

J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45.

13.

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.

Dunning AM, Healey CS, Pharoah PD, Foster NA, Lipscombe JM, Redman KL, Easton DF, Day NE, Ponder BA.

Br J Cancer. 1998 Jun;77(11):2045-7.

14.

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, et al.

Am J Hum Genet. 1998 Mar;62(3):676-89.

15.

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Parmigiani G, Berry D, Aguilar O.

Am J Hum Genet. 1998 Jan;62(1):145-58.

16.

An approximate model of polygenic inheritance.

Lange K.

Genetics. 1997 Nov;147(3):1423-30.

17.

Family history and the risk of breast cancer: a systematic review and meta-analysis.

Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA.

Int J Cancer. 1997 May 29;71(5):800-9.

18.

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA.

N Engl J Med. 1997 May 15;336(20):1401-8.

20.

Localization of the gene for Cowden disease to chromosome 10q22-23.

Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C.

Nat Genet. 1996 May;13(1):114-6.

PMID:
8673088
Items per page

Supplemental Content

Write to the Help Desk